Ortivus has entered into an agreement with its main owner regarding a bridge loan of 5.0 MSEK.

To strengthen the company's liquidity position in the aftermath of cyber-attack from last year, Ortivus has secured an agreement with Ponderus Invest for a bridge loan.

A contract has been signed between Ortivus and the company's main owner covering a bridge loan of 5.0 MSEK. This is to cover expenses for short-term deliveries and to strengthen the company's liquidity situation, which was severely impacted by the criminal cyber-attack the company was subjected to in July 2023.

A legal proceeding is underway to recover lost revenue and incurred expenses.

As previously communicated, the cyber-attack targeted one of Ortivus’ subcontractors and impacted some of the company's customers in the United Kingdom.

The loan is to be repaid by 30 August 2024.

About Ortivus

Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.

MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, – an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, – a tool for navigation and case management, and MobiMed Life – a range of stand-alone defibrillators.

MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com